2023
DOI: 10.1016/j.toxlet.2023.04.001
|View full text |Cite
|
Sign up to set email alerts
|

Monomethylarsonous acid binds to Cys-104α and Cys-112β of hemoglobin in acute promyelocytic leukemia patients treated with arsenic trioxide

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 31 publications
1
0
0
Order By: Relevance
“…Last year 1 we commented on the potential teratogenicity of As 2 O 3 therapy in pregnant patients with acute promyelocytic leukaemia (APL). To further understand erythrocyte As accumulation in APL patients, binding mechanisms between different As species and Hb were investigated using SEC-ICP-MS. 213 Consistently with previous in vitro studies, MMA demonstrated higher binding affinity for Hb than DMA and iAs in erythrocytes from 9 APL patients treated with As 2 O 3 . Accurate mass TOF-MS analysis of MMA–Hb complexes confirmed Cys-104α and Cys-112β as the reactive binding sites for MMA.…”
Section: Applications: Clinical and Biological Materialssupporting
confidence: 91%
“…Last year 1 we commented on the potential teratogenicity of As 2 O 3 therapy in pregnant patients with acute promyelocytic leukaemia (APL). To further understand erythrocyte As accumulation in APL patients, binding mechanisms between different As species and Hb were investigated using SEC-ICP-MS. 213 Consistently with previous in vitro studies, MMA demonstrated higher binding affinity for Hb than DMA and iAs in erythrocytes from 9 APL patients treated with As 2 O 3 . Accurate mass TOF-MS analysis of MMA–Hb complexes confirmed Cys-104α and Cys-112β as the reactive binding sites for MMA.…”
Section: Applications: Clinical and Biological Materialssupporting
confidence: 91%